231 related articles for article (PubMed ID: 21428920)
21. Growth or longevity: the TOR's decision on lifespan regulation.
Wei Y; Zhang YJ; Cai Y
Biogerontology; 2013 Aug; 14(4):353-63. PubMed ID: 23740528
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin enhances survival in a Drosophila model of mitochondrial disease.
Wang A; Mouser J; Pitt J; Promislow D; Kaeberlein M
Oncotarget; 2016 Dec; 7(49):80131-80139. PubMed ID: 27741510
[TBL] [Abstract][Full Text] [Related]
23. The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin.
Stylianou K; Petrakis I; Mavroeidi V; Stratakis S; Vardaki E; Perakis K; Stratigis S; Passam A; Papadogiorgaki E; Giannakakis K; Nakopoulou L; Daphnis E
Nephrol Dial Transplant; 2011 Feb; 26(2):498-508. PubMed ID: 20709738
[TBL] [Abstract][Full Text] [Related]
24. Prolidase-dependent regulation of TGF β (corrected) and TGF β receptor expressions in human skin fibroblasts.
Surazynski A; Miltyk W; Prokop I; Palka J
Eur J Pharmacol; 2010 Dec; 649(1-3):115-9. PubMed ID: 20868675
[TBL] [Abstract][Full Text] [Related]
25. Functional consequences of mTOR inhibition.
Sudarsanam S; Johnson DE
Curr Opin Drug Discov Devel; 2010 Jan; 13(1):31-40. PubMed ID: 20047144
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
27. [The mammalian TOR pathway is present in Trypanosoma cruzi. In silico reconstruction and possible functions].
Digirolamo FA; Miranda MR; Bouvier LA; Cámara MM; Cánepa GE; Pereira CA
Medicina (B Aires); 2012; 72(3):221-6. PubMed ID: 22763159
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
[TBL] [Abstract][Full Text] [Related]
29. Cell signaling. New mTOR targets Grb attention.
Yea SS; Fruman DA
Science; 2011 Jun; 332(6035):1270-1. PubMed ID: 21659593
[No Abstract] [Full Text] [Related]
30. Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: insights from zebrafish genetics.
Ding Y; Sun X; Redfield M; Kushwaha S; Xu X
Cell Cycle; 2012 Feb; 11(3):428-9. PubMed ID: 22262179
[No Abstract] [Full Text] [Related]
31. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease.
Santos RX; Correia SC; Cardoso S; Carvalho C; Santos MS; Moreira PI
J Neurochem; 2011 Jun; 117(6):927-36. PubMed ID: 21447003
[TBL] [Abstract][Full Text] [Related]
32. Metabolic regulation, mitochondria and the life-prolonging effect of rapamycin: a mini-review.
Pan Y; Nishida Y; Wang M; Verdin E
Gerontology; 2012; 58(6):524-30. PubMed ID: 22947849
[TBL] [Abstract][Full Text] [Related]
33. Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders.
Evangelisti C; Cenni V; Lattanzi G
Br J Clin Pharmacol; 2016 Nov; 82(5):1229-1244. PubMed ID: 26952863
[TBL] [Abstract][Full Text] [Related]
34. Gene expression analysis of mTOR pathway: association with human longevity.
Passtoors WM; Beekman M; Deelen J; van der Breggen R; Maier AB; Guigas B; Derhovanessian E; van Heemst D; de Craen AJ; Gunn DA; Pawelec G; Slagboom PE
Aging Cell; 2013 Feb; 12(1):24-31. PubMed ID: 23061800
[TBL] [Abstract][Full Text] [Related]
35. Comparative idiosyncrasies in life extension by reduced mTOR signalling and its distinctiveness from dietary restriction.
Garratt M; Nakagawa S; Simons MJ
Aging Cell; 2016 Aug; 15(4):737-43. PubMed ID: 27139919
[TBL] [Abstract][Full Text] [Related]
36. The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation.
Bjedov I; Rallis C
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899412
[TBL] [Abstract][Full Text] [Related]
37. Koschei the immortal and anti-aging drugs.
Blagosklonny MV
Cell Death Dis; 2014 Dec; 5(12):e1552. PubMed ID: 25476900
[TBL] [Abstract][Full Text] [Related]
38. mTOR Inhibitors in Cancer: What Can We Learn from Exceptional Responses?
Kwiatkowski DJ; Wagle N
EBioMedicine; 2015 Jan; 2(1):2-4. PubMed ID: 26137524
[No Abstract] [Full Text] [Related]
39. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging.
Kapahi P; Chen D; Rogers AN; Katewa SD; Li PW; Thomas EL; Kockel L
Cell Metab; 2010 Jun; 11(6):453-65. PubMed ID: 20519118
[TBL] [Abstract][Full Text] [Related]
40. Novel links in the plant TOR kinase signaling network.
Xiong Y; Sheen J
Curr Opin Plant Biol; 2015 Dec; 28():83-91. PubMed ID: 26476687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
